Gwénaëlle Carn is a Senior Clinical Project Manager at the Drugs for Neglected Diseases initiative - DNDi, where they manage the development of new therapies for Visceral Leishmaniasis. Previously, Gwénaëlle served as a Clinical Manager at DNDi, overseeing clinical trials in malaria and pediatric HIV across multiple countries. Their experience includes roles at Eli Lilly and Company, Sanofi, and multiple other organizations, where they coordinated and managed clinical studies in diverse fields such as psychiatry, metabolism, and oncology. Gwénaëlle holds a DEA in Neuropsychology from Université Claude Bernard Lyon 1 and a Master's degree in Physiology and Neuroscience from Université Pierre et Marie Curie.
Location
Geneva, Switzerland
This person is not in any offices